Skip to content
MatchScript
Menu

Head-to-head · The Match Score

Vaylen vs GoodRx

Both scored on the same six-factor Match Score. Vaylen wins this matchup with a 87 to 73 edge.

Higher Match Score

Vaylen

#8 · Grade B+

People who want maximum options — injectable, oral, compounded or brand — in one LegitScript-certified place.

Visit Vaylen
VS

GoodRx

#75 · Grade C

People who want self-pay brand-name Foundayo and Zepbound KwikPen at retail pharmacies.

Visit GoodRx

Factor by factor

The six sub-scores behind each Match Score. The quiz reweights these to your priorities — one provider can pull ahead for you on the factors you care about.

Budget Fit
82
78
Speed to Start
88
96
Formulary Match
94
71
Support Level
86
65
Flexibility
86
55
Transparency
88
72

Price, coverage & formulary

DetailVaylenGoodRx
Semaglutide$179/moNot disclosed
Tirzepatide$239/mo$299/mo (brand Zepbound)
CoverageAll 50 statesAll 50 states
Brand-name accessYesYes
Oral / sublingualYesInjectable only
Match Score87 · B+73 · C
Winner: Vaylen

Vaylen edges out GoodRx, 87 to 73 on the default Match Score. One of the widest formularies on the board — both molecules, an oral route, and brand access, all nationwide.

GoodRx is still a fair pick if its strengths line up with yours — best for: People who want self-pay brand-name Foundayo and Zepbound KwikPen at retail pharmacies.

Worth a look either way: our overall #1 pick is CoreAge Rx (Match Score 91) — nationwide access, both molecules at one flat price, easy to cancel. Or take the 6-question quiz to see your personalized match.

Assume any provider we list may compensate us, at no cost to you. It never changes the Match Score.

Full Vaylen reviewFull GoodRx review

More head-to-heads

Or browse alternatives to Vaylen and all comparisons.

Pricing, states and verification reflect each provider's public disclosures at last review; the Match Score and its sub-scores are our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.